CA Stock MarketDetailed Quotes

TTI Thiogenesis Therapeutics Corp

Watchlist
  • 0.650
  • -0.030-4.41%
15min DelayMarket Closed Nov 29 16:00 ET
29.92MMarket Cap-7222P/E (TTM)

Thiogenesis Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.81%-834.9K
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
Net income from continuing operations
37.71%-656.86K
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
Operating gains losses
----
----
----
----
----
----
----
----
11.94%-56.19K
-242.30%-125.67K
Remuneration paid in stock
-59.21%36.97K
-45.46%66.21K
-53.90%80.37K
-8.29%480.91K
-59.97%94.53K
-9.69%90.64K
26.19%121.39K
90.18%174.36K
7,183.87%524.37K
10,347.88%236.12K
Other non cashItems
----
----
----
----
----
----
----
----
--1.94M
--77.77K
Change In working capital
-675.30%-215.01K
-46.75%34K
-8,013.00%-1.37M
334.46%1.33M
5,114.12%1.28M
-343.98%-27.73K
108.19%63.85K
-92.34%17.26K
-212.25%-568.81K
-111.06%-25.53K
-Change in receivables
-1,502.92%-25.98K
270.53%48.06K
-127.84%-10.31K
-126.07%-29.33K
-25.26%-40.02K
4,417.07%1.85K
-51.76%-28.18K
-77.28%37.03K
167.32%112.48K
-154.89%-31.95K
-Change in prepaid assets
7,168.06%13.5K
10,943.00%22.09K
-56.48%12.79K
-10.69%-42.75K
-86.80%-72.15K
---191
--200
--29.39K
-221.34%-38.62K
---38.62K
-Change in payables and accrued expense
-589.02%-202.53K
-139.36%-36.15K
-2,683.69%-1.37M
318.73%1.41M
2,991.39%1.39M
-359.53%-29.39K
112.06%91.84K
-178.96%-49.15K
-200.10%-642.66K
-68.02%45.04K
Cash from discontinued investing activities
Operating cash flow
15.81%-834.9K
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
Investing cash flow
Cash flow from continuing investing activities
0
107.46K
-3.24M
Net business purchase and sale
----
----
----
--0
----
----
----
----
--107.46K
---3.24M
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
--107.46K
---3.24M
Financing cash flow
Cash flow from continuing financing activities
7K
0
462.5K
-49.29%4.12M
-49.80%4.12M
0
0
0
892.85%8.13M
5,475.92%8.21M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
-221.90%-175.17K
-82.60%25K
Net common stock issuance
----
----
----
-15.55%4.12M
----
----
----
----
623.16%4.88M
----
Proceeds from stock option exercised by employees
--7K
--0
--462.5K
--0
--0
--0
--0
--0
--3.42M
--3.31M
Cash from discontinued financing activities
Financing cash flow
--7K
--0
--462.5K
-49.29%4.12M
-49.80%4.12M
--0
--0
--0
892.85%8.13M
5,475.92%8.21M
Net cash flow
Beginning cash position
7.06%4.97M
3.86%5.52M
14.21%7.08M
9,805.77%6.2M
125.03%3.63M
109.57%4.64M
51.86%5.32M
9,951.69%6.2M
225.98%62.55K
2,297.75%1.61M
Current changes in cash
16.51%-827.9K
19.56%-551.12K
-75.24%-1.53M
-85.80%872.76K
-26.90%3.42M
-67.97%-991.64K
45.98%-685.15K
-126.37%-875.06K
12,094.89%6.14M
75,902.94%4.68M
Effect of exchange rate changes
124.29%4.69K
-126.98%-2.46K
-718.32%-19.03K
169.05%7.58K
119.38%20.08K
-74.59%-19.29K
148.38%9.12K
-101.90%-2.33K
-56.36%-10.98K
-818.63%-103.58K
End cash Position
14.19%4.15M
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
109.57%4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
Free cash from
15.81%-834.9K
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.81%-834.9K19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K
Net income from continuing operations 37.71%-656.86K25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K
Operating gains losses --------------------------------11.94%-56.19K-242.30%-125.67K
Remuneration paid in stock -59.21%36.97K-45.46%66.21K-53.90%80.37K-8.29%480.91K-59.97%94.53K-9.69%90.64K26.19%121.39K90.18%174.36K7,183.87%524.37K10,347.88%236.12K
Other non cashItems ----------------------------------1.94M--77.77K
Change In working capital -675.30%-215.01K-46.75%34K-8,013.00%-1.37M334.46%1.33M5,114.12%1.28M-343.98%-27.73K108.19%63.85K-92.34%17.26K-212.25%-568.81K-111.06%-25.53K
-Change in receivables -1,502.92%-25.98K270.53%48.06K-127.84%-10.31K-126.07%-29.33K-25.26%-40.02K4,417.07%1.85K-51.76%-28.18K-77.28%37.03K167.32%112.48K-154.89%-31.95K
-Change in prepaid assets 7,168.06%13.5K10,943.00%22.09K-56.48%12.79K-10.69%-42.75K-86.80%-72.15K---191--200--29.39K-221.34%-38.62K---38.62K
-Change in payables and accrued expense -589.02%-202.53K-139.36%-36.15K-2,683.69%-1.37M318.73%1.41M2,991.39%1.39M-359.53%-29.39K112.06%91.84K-178.96%-49.15K-200.10%-642.66K-68.02%45.04K
Cash from discontinued investing activities
Operating cash flow 15.81%-834.9K19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K
Investing cash flow
Cash flow from continuing investing activities 0107.46K-3.24M
Net business purchase and sale --------------0------------------107.46K---3.24M
Cash from discontinued investing activities
Investing cash flow --------------0------------------107.46K---3.24M
Financing cash flow
Cash flow from continuing financing activities 7K0462.5K-49.29%4.12M-49.80%4.12M000892.85%8.13M5,475.92%8.21M
Net issuance payments of debt --------------0-----------------221.90%-175.17K-82.60%25K
Net common stock issuance -------------15.55%4.12M----------------623.16%4.88M----
Proceeds from stock option exercised by employees --7K--0--462.5K--0--0--0--0--0--3.42M--3.31M
Cash from discontinued financing activities
Financing cash flow --7K--0--462.5K-49.29%4.12M-49.80%4.12M--0--0--0892.85%8.13M5,475.92%8.21M
Net cash flow
Beginning cash position 7.06%4.97M3.86%5.52M14.21%7.08M9,805.77%6.2M125.03%3.63M109.57%4.64M51.86%5.32M9,951.69%6.2M225.98%62.55K2,297.75%1.61M
Current changes in cash 16.51%-827.9K19.56%-551.12K-75.24%-1.53M-85.80%872.76K-26.90%3.42M-67.97%-991.64K45.98%-685.15K-126.37%-875.06K12,094.89%6.14M75,902.94%4.68M
Effect of exchange rate changes 124.29%4.69K-126.98%-2.46K-718.32%-19.03K169.05%7.58K119.38%20.08K-74.59%-19.29K148.38%9.12K-101.90%-2.33K-56.36%-10.98K-818.63%-103.58K
End cash Position 14.19%4.15M7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M109.57%4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M
Free cash from 15.81%-834.9K19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data